DE69620394T2 - Verwendung von forskolin oder diese enthaltende extrakte zur herstellung eines medikaments für die behandlung von alkoholsucht - Google Patents

Verwendung von forskolin oder diese enthaltende extrakte zur herstellung eines medikaments für die behandlung von alkoholsucht

Info

Publication number
DE69620394T2
DE69620394T2 DE69620394T DE69620394T DE69620394T2 DE 69620394 T2 DE69620394 T2 DE 69620394T2 DE 69620394 T DE69620394 T DE 69620394T DE 69620394 T DE69620394 T DE 69620394T DE 69620394 T2 DE69620394 T2 DE 69620394T2
Authority
DE
Germany
Prior art keywords
forskolin
treatment
medicine
producing
extracts containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69620394T
Other languages
English (en)
Other versions
DE69620394D1 (de
Inventor
Paolo Morazzoni
Ezio Bombardelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena SpA filed Critical Indena SpA
Publication of DE69620394D1 publication Critical patent/DE69620394D1/de
Application granted granted Critical
Publication of DE69620394T2 publication Critical patent/DE69620394T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE69620394T 1995-05-19 1996-05-09 Verwendung von forskolin oder diese enthaltende extrakte zur herstellung eines medikaments für die behandlung von alkoholsucht Expired - Fee Related DE69620394T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI951023A IT1275436B (it) 1995-05-19 1995-05-19 Uso della forskolina e di estratti che la contengono per il trattamento della alcol-dipendenza
PCT/EP1996/001952 WO1996036332A1 (en) 1995-05-19 1996-05-09 Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction

Publications (2)

Publication Number Publication Date
DE69620394D1 DE69620394D1 (de) 2002-05-08
DE69620394T2 true DE69620394T2 (de) 2002-10-02

Family

ID=11371634

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69620394T Expired - Fee Related DE69620394T2 (de) 1995-05-19 1996-05-09 Verwendung von forskolin oder diese enthaltende extrakte zur herstellung eines medikaments für die behandlung von alkoholsucht

Country Status (18)

Country Link
US (1) US5902823A (de)
EP (1) EP0825859B1 (de)
JP (1) JP3001641B2 (de)
KR (1) KR100423486B1 (de)
CN (1) CN1099286C (de)
AT (1) ATE215368T1 (de)
AU (1) AU697449B2 (de)
CA (1) CA2221592C (de)
DE (1) DE69620394T2 (de)
DK (1) DK0825859T3 (de)
ES (1) ES2175099T3 (de)
HK (1) HK1005651A1 (de)
HU (1) HU223474B1 (de)
IT (1) IT1275436B (de)
NO (1) NO316054B1 (de)
PT (1) PT825859E (de)
RU (1) RU2183455C2 (de)
WO (1) WO1996036332A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1001797B9 (de) 1997-07-30 2005-11-23 INDENA S.p.A. Sojaextrakt, verfahren zu dessen herstellung und pharmazeutische zusammensetzung
EP1645272A3 (de) * 1998-05-12 2008-11-05 The Endowment For Research In Human Biology, Inc. Daidzin-derivate zur Behandlung von Alkoholabhaengigkeit oder -Missbrauch
US20060122261A1 (en) * 2003-11-20 2006-06-08 Muhammed Majeed [method of preparing labdane diterpene composition, preferably isoforskolin and deacetylforskolin from forskolin extract and their use for promoting lean body mass and other applications]
US20100144885A1 (en) * 2006-09-29 2010-06-10 The Board Of Trustees Of The University Of Illinois Histone acetyl transferase activators and histone deacetylase inhibitors in the treatment of alcoholism

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4120975A (en) * 1976-08-26 1978-10-17 Fisons Limited Method of psychiatric conditions
US4782082A (en) * 1982-12-27 1988-11-01 Schering Corporation Method for treating allergic reactions with Forskolin
IL89530A0 (en) * 1989-03-08 1989-09-10 Jeffrey J Feigenbaum Compositions containing forskolin
US5366990A (en) * 1991-11-14 1994-11-22 Reid Larry D Method for treating alcohol abuse and alcoholism

Also Published As

Publication number Publication date
ITMI951023A0 (it) 1995-05-19
AU697449B2 (en) 1998-10-08
JP3001641B2 (ja) 2000-01-24
EP0825859A1 (de) 1998-03-04
ES2175099T3 (es) 2002-11-16
PT825859E (pt) 2002-08-30
CA2221592A1 (en) 1996-11-21
CN1184422A (zh) 1998-06-10
HUP9801236A2 (hu) 2000-06-28
US5902823A (en) 1999-05-11
CA2221592C (en) 2002-07-09
HUP9801236A3 (en) 2001-09-28
HK1005651A1 (en) 1999-01-22
DK0825859T3 (da) 2002-07-29
DE69620394D1 (de) 2002-05-08
AU5816396A (en) 1996-11-29
WO1996036332A1 (en) 1996-11-21
ATE215368T1 (de) 2002-04-15
EP0825859B1 (de) 2002-04-03
KR19990014876A (ko) 1999-02-25
KR100423486B1 (ko) 2004-06-05
RU2183455C2 (ru) 2002-06-20
ITMI951023A1 (it) 1996-11-19
NO975155D0 (no) 1997-11-10
NO316054B1 (no) 2003-12-08
IT1275436B (it) 1997-08-07
JPH11500738A (ja) 1999-01-19
NO975155L (no) 1997-11-10
HU223474B1 (hu) 2004-07-28
CN1099286C (zh) 2003-01-22

Similar Documents

Publication Publication Date Title
DE69629184D1 (de) Verwendung von vitamin d2 oder vitamin d4-derivaten zur herstellung eines medikamentes zur behandlung des sekundären hyperparathyroidismus
DE69616376D1 (de) Verwendung von Tiagabin zur Behandlung von Schlafstörungen
DE69428791T2 (de) Verwendung vonModafinil zur Behandlung von Atemstillstand im Schlaf und zentral erregten Atembeschwerden
ATE262895T1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
ATE321548T1 (de) Verwendung von statin zur behandlung von hauterkrankungen
PT638075E (pt) Inibidor da reaccao de maillard
DE59914712D1 (de) Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden
DE69620394T2 (de) Verwendung von forskolin oder diese enthaltende extrakte zur herstellung eines medikaments für die behandlung von alkoholsucht
DE69329687T2 (de) Verwendung von aspirin zur herstellung eines arzneimittels zur verbesserung fer blutperfusion des uterus
DE69620786T2 (de) Verwendung von cholinesterase-inhibitoren für die herstellung eines medikaments zur behandlung von xerostomie
DE69720064D1 (de) Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen
ATE189385T1 (de) Verwendung von benzonaphtalene-derivaten zur herstellung eines arzneimittels zur behandlung von krankheiten des nervensystems
ATE222762T1 (de) 4-hydroxycoumarin-3-carboxamide für die behandlung von nicht-insulin-abhängigen diabetes mellitus
DE69623767D1 (de) Verwendung von pyrrolidinderivaten zur behandlung des alkoholismus
ATE186640T1 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung neurogenerativer erkrankungen
DE69424415T2 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
DE69109293D1 (de) Verwendung von 20(r)-22-oxa-vitamin d analoge zur herstellung eines medikaments für die behandlung des altershaut.
DE69610045T2 (de) Verwendung eines Rohpflanzenextraktes zur Herstellung eines Arzneimittels zur Behandlung von HIV-Infektionen
DE69632117D1 (de) Verwendung von 8,9-Dehydroestron zur Herstellung eines Arzneimittels zur Behandlung von durch freie Radikale verursachte Krankheiten
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
DE69507309D1 (de) Verfahren zur herstellung von 3,4-dihydroxy-5-nitrobenzaldehyd
DE59409813D1 (de) Imidazolochinoxalinone zur behandlung zentralnervöser erkrankungen
DE69832796D1 (de) Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen
DE69718928D1 (de) Verwendung von efaroxan zur herstellung eines arzneimittels zur behandlung von huntington krankheit
DE69625819D1 (de) Die verwendung von ondansetron zur herstellung eines medikamentes zur behandlung von tremor

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC

8339 Ceased/non-payment of the annual fee